Pioneer of Interventional Oncology in China | Generated by AI

Home 2026.04

Question: Who is Luo Pengfei (罗鹏飞), and what are his background, career achievements, and contributions to medicine?

Answer:

Professor Luo Pengfei (罗鹏飞) — Comprehensive Introduction

Overview

Professor Luo Pengfei is one of China’s most distinguished experts in tumor interventional radiology (肿瘤放射介入学). He is widely regarded as a founding pioneer of interventional medicine in Guangdong Province and a key figure in the establishment of the specialty across China. He is a senior expert in interventional radiology and oncology, recognized as a Central Health Bureau consultation expert, and enjoys the State Council’s Special Government Allowance (国务院特殊津贴).

Education & Early Career

Luo Pengfei graduated from the Sun Yat-sen University School of Medicine (中山大学医疗系) in 1970, and in 1982 completed his master’s degree in radiology at Kunming Medical University (昆明医科大学). His primary fields have been radiology and oncology, with a specialty in Interventional Therapy of Cancer (ITC).

He grew up in a small town in Zhuhai, Guangdong, and pursued his dream of medicine by entering Sun Yat-sen University’s medical program. He later specialized in radiology and clinical oncology.

International Training & Academic Engagement

In 1987, after a rigorous selection process, he was chosen by the state to study interventional therapy (ITC) as a visiting scholar at Kobe University School of Medicine in Japan for over a year, where he was exposed to advanced medical equipment and techniques.

He attended the Radiological Society of North America (RSNA) conference in Chicago five times — one of the world’s largest professional medical meetings — and also participated multiple times in the Asia-Pacific cardiovascular and interventional radiology conference (CVIR) held in Europe, Japan, and South Korea. In 1995, he presented a paper on interventional treatment of liver cancer at the Seoul international conference, attracting wide attention.

Founding China’s First Interventional Oncology Department

In late 1988, the clinical team he led established China’s first dedicated “Interventional Therapy Department” (介入治疗科) at Guangdong Provincial People’s Hospital — introducing interventional oncology as the fourth major mode of tumor treatment alongside surgery, chemotherapy, and radiotherapy. This marked a new chapter in China’s tumor treatment history.

Major Institutional Roles & Positions

Professor Luo has held a wide range of distinguished positions, including:

He currently practices at Guangzhou Xinshi Hospital (广州新市医院 / Guangdong University of Pharmacy Affiliated Third Hospital), where he is the academic leader of the tumor minimally invasive treatment center.

Clinical Specialties & Achievements

He has extensive clinical experience in interventional treatment of all types of tumors, particularly liver tumors, lung cancer, and colorectal cancer with liver metastases.

Key clinical milestones include:

Research & Publications

As first author, he published 37 papers in core medical journals, which have been cited 325 times; as co-author, he contributed to 95 papers cited 1,215 times. He has chief-edited or co-edited five authoritative medical texts, including Tumor Interventional Diagnosis and Treatment (肿瘤介入诊疗学) and Clinical Interventional Therapy (临床介入治疗学), which have long served as standard professional references for Chinese physicians in this field.

In 2023, he completed his latest monograph: Luo Pengfei’s Formula-Based Tumor Therapy (罗鹏飞程式肿瘤诊疗法)*, which also secured international patent protection.

The “Luo Pengfei Protocol” — International Patent Innovation

In October 2022, the “Luo Pengfei Formula-Based Tumor Diagnosis and Treatment Method” (罗鹏飞程式肿瘤诊疗法) received an international patent from the Benelux (Belgium-Netherlands-Luxembourg) Patent Office, Patent No. LU501835.

This system integrates five advanced technologies: intratumoral drug injection, tumor-feeding vessel embolization, physical cold/heat or particle ablation, stent implantation, and hyperthermia. The approach is designed to biologically inactivate tumors while minimizing damage to surrounding organs, achieving a tumor biological activity inactivation rate reported at 92%, with a 70% reduction in complications.

Awards & Honors

His major recognitions include:

Teaching & Mentorship

Over his career, he has trained more than 200 doctoral and master’s students as well as visiting scholars, most of whom have gone on to become leading figures in interventional radiology across various provinces and nationally, with many presenting at prestigious forums such as RSNA.

Summary

Professor Luo Pengfei represents a foundational figure in Chinese modern oncology and interventional medicine. His four-decade career spans pioneering the discipline, training generations of specialists, authoring landmark textbooks, and developing an internationally patented, systematic tumor treatment protocol. He embodies the transformation of Chinese interventional oncology from a follower of international trends into an innovator recognized on the global stage.

References:

Back Donate